$142.8
+6.63
(+4.87%)▲
5.06%
Downside
Day's Volatility :5.55%
Upside
0.52%
37.39%
Downside
52 Weeks Volatility :37.39%
Upside
0.0%
Period | Ensign Group Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 16.14% | 6.5% | 0.0% |
6 Months | 18.52% | 7.1% | 0.0% |
1 Year | 48.41% | 9.8% | 0.0% |
3 Years | 60.05% | 14.2% | -20.2% |
Market Capitalization | 7.8B |
Book Value | $27.95 |
Dividend Share | 0.235 |
Dividend Yield | 0.17% |
Earnings Per Share (EPS) | 3.79 |
PE Ratio | 35.93 |
PEG Ratio | 1.48 |
Wall Street Target Price | 138.4 |
Profit Margin | 5.67% |
Operating Margin TTM | 8.14% |
Return On Assets TTM | 4.02% |
Return On Equity TTM | 15.08% |
Revenue TTM | 3.9B |
Revenue Per Share TTM | 68.84 |
Quarterly Revenue Growth YOY | 13.900000000000002% |
Gross Profit TTM | 534.9M |
EBITDA | 336.4M |
Diluted Eps TTM | 3.79 |
Quarterly Earnings Growth YOY | 0.13 |
EPS Estimate Current Year | 5.4 |
EPS Estimate Next Year | 5.96 |
EPS Estimate Current Quarter | 1.28 |
EPS Estimate Next Quarter | 1.31 |
What analysts predicted
Downside of 3.08%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.1B | ↑ 12.12% |
Net Income | 92.4M | ↑ 128.2% |
Net Profit Margin | 4.45% | ↑ 2.26% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↓ 1.78% |
Net Income | 110.5M | ↑ 19.67% |
Net Profit Margin | 5.43% | ↑ 0.98% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↑ 17.98% |
Net Income | 170.5M | ↑ 54.23% |
Net Profit Margin | 7.1% | ↑ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.6B | ↑ 9.36% |
Net Income | 194.7M | ↑ 14.18% |
Net Profit Margin | 7.41% | ↑ 0.31% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↑ 15.15% |
Net Income | 224.7M | ↑ 15.43% |
Net Profit Margin | 7.43% | ↑ 0.02% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.7B | ↑ 23.27% |
Net Income | 209.4M | ↓ 6.8% |
Net Profit Margin | 5.61% | ↓ 1.82% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 809.5M | ↑ 5.13% |
Net Income | 60.5M | ↑ 7.64% |
Net Profit Margin | 7.47% | ↑ 0.17% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 886.8M | ↑ 9.55% |
Net Income | 59.9M | ↓ 1.02% |
Net Profit Margin | 6.75% | ↓ 0.72% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 921.3M | ↑ 3.89% |
Net Income | 64.0M | ↑ 6.92% |
Net Profit Margin | 6.95% | ↑ 0.2% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 940.8M | ↑ 2.11% |
Net Income | 63.9M | ↓ 0.2% |
Net Profit Margin | 6.79% | ↓ 0.16% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 980.4M | ↑ 4.21% |
Net Income | 21.7M | ↓ 66.04% |
Net Profit Margin | 2.21% | ↓ 4.58% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 982.9M | ↑ 0.26% |
Net Income | 68.8M | ↑ 217.34% |
Net Profit Margin | 7.0% | ↑ 4.79% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.2B | ↑ 7.21% |
Total Liabilities | 579.6M | ↓ 3.78% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 99.83% |
Total Liabilities | 1.7B | ↑ 194.29% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↑ 7.78% |
Total Liabilities | 1.7B | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 11.98% |
Total Liabilities | 1.8B | ↑ 5.88% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 21.1% |
Total Liabilities | 2.2B | ↑ 20.47% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 4.2B | ↑ 21.02% |
Total Liabilities | 2.7B | ↑ 21.65% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 3.5B | ↑ 5.72% |
Total Liabilities | 2.2B | ↑ 5.74% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.9B | ↑ 11.88% |
Total Liabilities | 2.5B | ↑ 15.4% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.0B | ↑ 2.33% |
Total Liabilities | 2.6B | ↑ 0.65% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.1B | ↑ 3.28% |
Total Liabilities | 2.6B | ↑ 2.25% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 4.2B | ↑ 2.34% |
Total Liabilities | 2.7B | ↑ 2.43% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 4.3B | ↑ 3.13% |
Total Liabilities | 2.7B | ↑ 1.67% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 210.3M | ↑ 188.27% |
Investing Cash Flow | -151.2M | ↑ 41.86% |
Financing Cash Flow | -70.3M | ↓ 484.99% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 168.9M | ↓ 19.67% |
Investing Cash Flow | -247.0M | ↑ 63.36% |
Financing Cash Flow | 83.3M | ↓ 218.39% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 373.4M | ↑ 121.01% |
Investing Cash Flow | -58.7M | ↓ 76.25% |
Financing Cash Flow | -137.3M | ↓ 264.87% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 275.7M | ↓ 26.16% |
Investing Cash Flow | -173.9M | ↑ 196.44% |
Financing Cash Flow | -76.1M | ↓ 44.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 272.5M | ↓ 1.15% |
Investing Cash Flow | -186.2M | ↑ 7.06% |
Financing Cash Flow | -32.3M | ↓ 57.63% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 50.2M | ↓ 45.77% |
Investing Cash Flow | -42.4M | ↓ 36.86% |
Financing Cash Flow | -359.0K | ↓ 82.62% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 48.3M | ↓ 3.65% |
Investing Cash Flow | -36.0M | ↓ 15.18% |
Financing Cash Flow | -1.7M | ↑ 366.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 119.7M | ↑ 147.68% |
Investing Cash Flow | -26.5M | ↓ 26.43% |
Financing Cash Flow | -269.0K | ↓ 83.93% |
Sell
Neutral
Buy
Ensign Group Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Ensign Group Inc | 12.85% | 18.52% | 48.41% | 60.05% | 144.89% |
![]() Fresenius Medical Care Ag | 6.75% | 1.59% | -22.77% | -49.63% | -45.76% |
![]() Hca Holdings, Inc. | 3.62% | 24.47% | 25.02% | 43.55% | 143.2% |
![]() Tenet Healthcare Corp. | 10.35% | 80.65% | 95.1% | 108.93% | 580.33% |
![]() Universal Health Services Inc. | 8.08% | 30.09% | 44.94% | 32.59% | 34.96% |
![]() Davita Healthcare Partners Inc. | 0.24% | 32.97% | 40.81% | 19.01% | 139.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Ensign Group Inc | 35.93 | 35.93 | 1.48 | 5.4 | 0.15 | 0.04 | 0.0 | 27.95 |
![]() Fresenius Medical Care Ag | 22.58 | 22.58 | 0.39 | 1.5 | 0.05 | 0.03 | 0.03 | 47.4 |
![]() Hca Holdings, Inc. | 16.16 | 16.16 | 1.44 | 21.86 | 0.74 | 0.11 | 0.01 | -6.06 |
![]() Tenet Healthcare Corp. | 5.46 | 5.46 | 1.74 | 8.98 | 0.54 | 0.07 | NA | 16.09 |
![]() Universal Health Services Inc. | 15.8 | 15.8 | 1.87 | 13.79 | 0.13 | 0.06 | 0.0 | 93.48 |
![]() Davita Healthcare Partners Inc. | 16.31 | 16.31 | 1.16 | 9.32 | 0.43 | 0.06 | NA | 10.56 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Ensign Group Inc | Buy | $7.8B | 144.89% | 35.93 | 5.67% |
![]() Fresenius Medical Care Ag | Hold | $11.9B | -45.76% | 22.58 | 2.48% |
![]() Hca Holdings, Inc. | Buy | $90.1B | 143.2% | 16.16 | 8.4% |
![]() Tenet Healthcare Corp. | Buy | $14.6B | 580.33% | 5.46 | 12.54% |
![]() Universal Health Services Inc. | Hold | $12.4B | 34.96% | 15.8 | 5.57% |
![]() Davita Healthcare Partners Inc. | Hold | $12.6B | 139.9% | 16.31 | 6.61% |
Insights on Ensign Group Inc
Revenue is up for the last 13 quarters, 627.25M → 982.90M (in $), with an average increase of 3.7% per quarter
Netprofit is up for the last 2 quarters, 21.69M → 68.83M (in $), with an average increase of 68.5% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 95.1% return, outperforming this stock by 46.7%
In the last 3 years, Tenet Healthcare Corp. has given 108.9% return, outperforming this stock by 48.9%
BlackRock Inc
Vanguard Group Inc
Wasatch Advisors LP
Capital Research Global Investors
Fuller & Thaler Asset Management Inc
State Street Corporation
In the quarter ending March,2024. Ensign Group Inc has declared dividend of $0.06
Read Moreskilled nursing/assisted living
Organization | Ensign Group Inc |
Employees | 35300 |
CEO | Mr. Christopher R. Christensen |
Industry | Health Services |
Outfront Media Inc.
$142.80
+4.87%
Blackrock Short Duration Bond Etf
$142.80
+4.87%
Helmerich & Payne, Inc.
$142.80
+4.87%
Crane Nxt Co
$142.80
+4.87%
Liberty Global Plc - Class C Shares
$142.80
+4.87%
Waystar Holding Corp.
$142.80
+4.87%
Apogee Therapeutics
$142.80
+4.87%
Wd-40 Co
$142.80
+4.87%
Nnn Reit Inc.
$142.80
+4.87%